Rare diseases
Investigational molecules
Locations
Clinical trials in Slovakia – page 25490 clinical trials in Slovakia across 18 research sites in 92 cities. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SlovakiaKlinickeSkusky.sk(opens in a new tab)SlovakiaSlovakiaSlovakiaSlovakiaSlovakiaSlovakiaSlovakiaSlovakiaSlovakiaSlovakiaSlovakiaSlovakiaWhere most of the country's trials are run
Shares are of these cities' trials together.
92 cities, A–Z – pick yours to filter the trials
What the registry says about research in the country
Slovakia participates in clinical research addressing a broad spectrum of cardiovascular conditions, including atherosclerotic cardiovascular disease, heart failure, and atrial fibrillation. These studies evaluate novel therapeutic approaches aimed at reducing cardiovascular events, preventing stroke, and managing conditions such as acute myocardial infarction and hypertension. Research efforts focus on anticoagulation strategies, heart failure management with reduced or preserved ejection fraction, and interventions for patients with elevated cardiovascular risk.
Trials in this area also investigate the role of novel agents in managing complications such as peripheral arterial disease and reducing recurrent cardiovascular events following myocardial infarction, contributing to improved outcomes for patients with complex cardiovascular profiles.
Clinical trials in oncology represent a significant portion of Slovakia's research landscape, spanning solid tumors and hematologic malignancies. Studies focus on breast cancer, non-small cell lung cancer, prostate cancer, colorectal cancer, and various lymphomas. Research includes evaluation of targeted therapies, immunotherapies, and combination regimens designed to improve progression-free survival and overall outcomes. Trials address both early-stage and metastatic disease, with emphasis on precision medicine approaches.
Pediatric oncology trials are also conducted, including studies in acute lymphoblastic leukemia, neuroblastoma, and Hodgkin lymphoma, reflecting a commitment to advancing treatment options across age groups.
Slovakia actively participates in research on inflammatory bowel diseases, particularly Crohn's disease and ulcerative colitis. These trials evaluate the efficacy and safety of novel biologics and targeted therapies aimed at achieving clinical remission, endoscopic improvement, and transmural healing. Studies focus on both induction and maintenance treatment strategies for patients with moderate to severe disease activity.
Additional gastroenterology research includes studies on eosinophilic esophagitis, primary biliary cholangitis, and non-alcoholic steatohepatitis, addressing diverse digestive system disorders.
Clinical research in rheumatology encompasses studies on rheumatoid arthritis, psoriatic arthritis, systemic lupus erythematosus, and other autoimmune conditions. Trials investigate targeted therapies, including JAK inhibitors and biologics, for patients with moderate to severe disease. Research also addresses rare conditions such as active idiopathic inflammatory myopathies and ANCA-associated vasculitis.
Studies also evaluate treatments for musculoskeletal conditions such as rotator cuff tendinopathy, reflecting a comprehensive approach to rheumatologic and musculoskeletal health.
Slovakia contributes to clinical trials in neurology, with particular emphasis on multiple sclerosis and epilepsy. Research focuses on relapsing forms of MS, including relapsing-remitting and secondary progressive subtypes, evaluating disease-modifying therapies aimed at reducing relapse rates and slowing disease progression. Studies also address pediatric MS populations.
Additional neurological research includes studies on Parkinson's disease, chronic inflammatory demyelinating polyneuropathy, and multifocal motor neuropathy, addressing a range of neurodegenerative and neuromuscular conditions.
Clinical trials in endocrinology focus on type 2 diabetes, obesity, and metabolic syndrome. Research evaluates novel glucose-lowering agents, weight management therapies, and interventions for patients with cardiovascular comorbidities. Studies also address complications such as diabetic macular edema and early worsening of diabetic retinopathy with intensified glycemic control.
Lipid disorder research includes studies on familial chylomicronemia syndrome and atherosclerotic cardiovascular disease with elevated lipoprotein(a), addressing metabolic risk factors for cardiovascular events.
Slovakia participates in ophthalmology trials targeting retinal vascular diseases and degenerative conditions. Research focuses on diabetic macular edema, neovascular age-related macular degeneration, and retinal vein occlusion. Studies evaluate anti-VEGF therapies and novel agents with extended dosing intervals to reduce treatment burden while maintaining visual acuity.
Additional ophthalmology research includes studies on retinopathy of prematurity, myopia, and thyroid eye disease, reflecting diverse approaches to preserving and improving vision.
Clinical research in dermatology addresses chronic inflammatory skin conditions such as atopic dermatitis, psoriasis, and hidradenitis suppurativa. Trials evaluate biologics and targeted therapies for moderate to severe disease, including pediatric populations. Studies also investigate rare conditions such as bullous pemphigoid and vitiligo.
Research also includes studies on chronic spontaneous urticaria and chronic inducible urticaria, addressing conditions that significantly impact quality of life.
Slovakia contributes to nephrology research focusing on chronic kidney disease, IgA nephropathy, and related complications. Studies evaluate therapies aimed at reducing proteinuria, slowing disease progression, and managing anemia associated with CKD. Research also addresses rare kidney disorders and glomerular diseases.
Additional research includes studies on atypical hemolytic uremic syndrome and immune complex-mediated membranoproliferative glomerulonephritis, addressing complex renal pathologies.
Clinical trials in respiratory medicine focus on chronic obstructive pulmonary disease, asthma, and infectious respiratory conditions. Research evaluates bronchodilators, anti-inflammatory therapies, and biologics for patients with moderate to severe disease. Studies also address cystic fibrosis and bronchiectasis.
Research also includes studies on pulmonary arterial hypertension and respiratory syncytial virus infections, reflecting a comprehensive approach to respiratory health across diverse patient populations.
Slovakia participates in infectious disease research addressing bacterial infections, viral diseases, and antimicrobial resistance. Studies evaluate novel antibiotics for complicated urinary tract infections, hospital-acquired pneumonia, and complicated intra-abdominal infections. Research also focuses on viral infections including COVID-19 and HPV-associated conditions.
Additional research includes studies on Lyme borreliosis and prevention strategies for HPV-associated infections and cancers, contributing to improved infection control and prevention.
Clinical research in psychiatry addresses major depressive disorder, schizophrenia, and neurodegenerative conditions with psychiatric manifestations. Studies evaluate novel antidepressants, antipsychotics, and therapies for conditions such as Alzheimer's disease psychosis and agitation in dementia. Research also focuses on anxiety disorders and bipolar disorder.
Studies also address tardive dyskinesia and cognitive impairment in early Alzheimer's disease, reflecting comprehensive approaches to mental health and neurodegenerative conditions.
Slovakia contributes to hematology research addressing hemophilia, chronic myeloid leukemia, and thrombotic conditions. Studies evaluate prophylactic therapies for hemophilia patients with or without inhibitors, novel anticoagulants, and treatments for hyperkalemia. Research also includes rare blood disorders and coagulation abnormalities.
Additional research addresses ataxia telangiectasia and other rare hematologic conditions, contributing to improved management of complex blood disorders.
Clinical trials in Slovakia include research on rare genetic and metabolic disorders such as Niemann-Pick disease type C, osteogenesis imperfecta, and hypophosphatasia. Studies evaluate disease-modifying therapies and supportive care strategies for these challenging conditions. Research also addresses primary immunodeficiency diseases and hereditary angioedema.
Additional research includes studies on transthyretin amyloidosis with cardiomyopathy and other rare conditions, reflecting commitment to advancing care for underserved patient populations.
Slovakia participates in research on allogeneic stem cell transplantation for hematologic malignancies, particularly in pediatric populations with acute lymphoblastic leukemia. Studies evaluate conditioning regimens, donor selection strategies, and management of transplant-related complications. Research also includes CAR T-cell therapy trials for lymphomas and other hematologic cancers.
These studies contribute to improving transplantation outcomes and expanding cellular therapy options for patients with life-threatening hematologic conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
